SIX1 and cancer: As the activator of the Six1–Eya bipartite transcription factor complex, Eya mediates critical functions in cancer by promoting proliferation, angiogenesis, plasticity, immune evasion, invasion, metastasis, and epithelial–mesenchymal transition (4, 5, 14, 21, 22, 23, 24).